Navigation Links
Depomed Reports Second Quarter 2014 Financial Results
Date:8/6/2014

luted share
  • $223.7 million of cash and marketable securities and no debt outstanding as of June 30, 2014, an increase of $10.6 million for the quarter
  • Completed bench trial in ANDA litigation related to Gralise with a ruling expected in short order
  • Srinivas G. Rao, MD, PhD, joined Depomed in July as Chief Medical Officer and announced that R. Scott Shively will join the company as Chief Commercial Officer in September
  • "Gralise and our recent acquisitions, CAMBIA and Lazanda, led the way to a strong quarter, doubling our net product sales over the same period last year.  All four of our products showed prescription growth in Q2 compared to Q1 2014," said Jim Schoeneck, President and Chief Executive Officer of Depomed.  "We believe the growth of our product revenues in Q2 and the integration of new products into our commercial organization demonstrate our ability to build a growth-oriented specialty pharmaceutical company focused on pain and central nervous system disorders. We are also thrilled to add Srini and Scott to our leadership team, increasing our depth and expertise in the pain and CNS markets.  For the remainder of 2014, we are focused on growing product revenues, acquiring additional assets that will enhance our product portfolio and managing expenses to continue to operate at positive cash flow."

    Accounting Treatment for the Sale of Type 2 Diabetes Royalty and Milestone Interests to PDLIn October 2013, Depomed sold interests in future royalty and milestone payments in the Type 2 diabetes therapeutic area to PDL Biopharma, Inc. (PDL) for $240.5 million. As a result of ongoing supply order obligations with respect to the underlying royalties, Depomed is accounting for this transaction under the debt accounting method. Although the royalty and milestone payments were sold to PDL, debt accounting requires the Company to continue to recognize the underlying royalties and milestones as revenu
    '/>"/>

    SOURCE Depomed, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. Depomed Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals, Inc.
    2. Depomed To Present At Jefferies 2012 Global Health Care Conference
    3. Depomed Announces Filing Of Shelf Registration To Replace Existing Shelf
    4. Depomed To Present At JMP Securities 7th Annual Healthcare Conference
    5. Depomed To Report Second Quarter Fiscal Year 2012 Financial Results On Thursday, August 2, 2012
    6. Depomed To Present At Stifel Nicolaus 2012 Healthcare Conference
    7. Depomed To Present At Morgan Stanley 2012 Healthcare Conference
    8. Depomed To Present At UBS Global Life Sciences Conference
    9. Depomed To Report Third Quarter Fiscal Year 2012 Financial Results On Monday, November 5, 2012
    10. Depomed Reports Third Quarter Financial Results
    11. Depomed To Present At Lazard 2012 Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/4/2015)... 4, 2015   The New York Times ... internationally acclaimed plastic surgeon, Dr. Rod Rohrich . ... is proven to reduce fat deposits under the chin. ... The active ingredient in Kybella, deoxycholic acid, dissolves ... the ability to reshape this area without surgery. "So ...
    (Date:5/4/2015)... , May 4, 2015 Former NASA ... News online last week where he discussed Theradome™, the ... be FDA-cleared. The FOX segment shows firsthand how, via ... affordable hair loss solution that will not require surgery ... the mitochondria at the base of the hair follicle, ...
    (Date:5/4/2015)... Conn. , May 4, 2015 /PRNewswire/ ... market private equity firm, announced today that ... portfolio company, BioPharm Communications. BioPharm specializes in the ... programs for the pharmaceutical and biotechnology industries. ... repaid to its shareholders half of their ...
    Breaking Medicine Technology:Dr. Rod Rohrich Provides Medical Expertise on Kybella 2Dr. Rod Rohrich Provides Medical Expertise on Kybella 3FOX News Features Theradome as the Take-Home Solution to Tackle Baldness 2Southfield Capital and BioPharm Communications Announce Dividend Recapitalization 2
    ... , ST. LOUIS , ... today announced that it will broadcast its fourth quarter earnings results ... Thursday, February 4, 2010 at 11:00 a.m. Central Time ... through InterCall at http://tinyurl.com/yi4q09 .  Access to the live audio ...
    ... , RICHMOND, Calif. , Jan. 27 ... the company will release its fourth quarter and full year 2009 financial ... The press release will be followed by a conference call at ... telephone and webcast. During the conference call, the company will review the ...
    Cached Medicine Technology:Young Innovations, Inc. Provides 4th Quarter Conference Call Details 2Sangamo BioSciences Announces Fourth Quarter and Full Year 2009 Conference Call and Webcast 2
    (Date:5/4/2015)... The American Telemedicine Association (ATA) today released an update ... in coverage and reimbursement, and physician practice standards and ... Reports last September, many state regulating bodies responded by ... delivery in their state,” said Jonathan Linkous, CEO of ... nation, ATA reevaluated the indicators for each state and ...
    (Date:5/4/2015)... 2015 METTLER TOLEDO has announced ... Data Integrity in a GXP Regulated Laboratory ", ... This webinar will be presented on May 27, ... integrity is a critical component of pharmaceutical product ... However, in recent years an increasing number of ...
    (Date:5/4/2015)... Washington, DC (PRWEB) May 04, 2015 ... of Kit Check as a finalist for the EY ... Washington Region. The awards program recognizes entrepreneurs who ... innovation, financial performance and personal commitment to their businesses ... finalist by a panel of independent judges. Award ...
    (Date:5/4/2015)... Ticket Down is a reputable source for authentic ... in Columbia, South Carolina. Fans of Paul McCartney have ... tour which originally kicked off in 2013. The most visited ... the legendary performer recently announced that he would be adding ... June 21st, in Charlottesville, VA at John Paul Jones Arena ...
    (Date:5/4/2015)... San Diego, CA (PRWEB) May 04, 2015 ... hosted a ribbon cutting ceremony at their brand new, ... of this year. The new building will not only ... patient population, but will also offer community and educational ... , The new facility is located next door to ...
    Breaking Medicine News(10 mins):Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 2Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 3Health News:METTLER TOLEDO Announces Live Webinar on the Importance of Data Integrity in a GXP Regulated Laboratory 2Health News:EY announces Kit Check CEO and Co-founder Kevin MacDonald as an EY Entrepreneur Of The Year® 2015 Award finalist in the Greater Washington Region 2Health News:Paul McCartney Tickets at Colonial Life Arena in Columbia, SC: Ticket Down Slashes Paul McCartney Ticket Prices in Columbia, South Carolina at Colonial Life Arena 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3
    ... Oct. 28 A few spaces remain for the ... Symposium on Nov. 4-5, 2009. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ... writers and journalists and will focus on how FDA ... , This year,s symposium will feature an address by ...
    ... 28 If we get a boo-boo, we might know to ... kiss it and make it all better. But, what if ... us who aren,t prepared for dental emergencies can quickly get back ... Company at: , http://inr.mediaseed.tv/oneClip_C/?feed=Ss8P5Rb1iQulYDAELUR0M_kpwKp_6YSM , Medialink ...
    ... Oct. 28 Collagen Matrix, Inc., the leader in ... Shu-Tung Li, the Company,s Founder, President, and Chief Executive ... Executive of the Year category of the 2009 New ... Politziner and Mattia, Certified Public Accountants and Consultants. ...
    ... Inc . (Pink Sheets: JEDM) ( www.jedimindinc.com ) ... excellent cash position to expand both the gaming and medical divisions ... in excess of $500,000 of working capital which is being used ... computer hardware and software applications to the latest standards. , ...
    ... Research Foundation (LRF) is pleased to announce that David ... Thomas Kipps, MD, PhD, Moores Cancer Center, University of ... round of funding under the Foundation,s Chronic Lymphocytic Leukemia ... Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) are ...
    ... and mental health in study , WEDNESDAY, Oct. 28 ... the emotional and mental well-being of breast cancer patients, ... 130 patients at Saint Joseph Hospital in Chicago, aged ... meditation group or to a usual care control group. ...
    Cached Medicine News:Health News:Shu-Tung Li, Founder and CEO of Collagen Matrix, Inc. Honored as 2009 New Jersey Executive of the Year Finalist and Company Named One of Fifty Fastest Growing Companies 2Health News:Jedi Mind, Inc. in Excellent Financial Shape to Expand Business 2Health News:Lymphoma Research Foundation announces recipients of CLL/SLL Research Initiative grants 2Health News:Meditation May Reduce Stress in Breast Cancer Patients 2
    ... an integral part of the enzymatic cascade ... as well as the degradation of Bradykinin. ... is primarily located in endothelial cells. ACE ... for sarcoidosis and myocardial infarction but is ...
    ... and quantitative evaluation of pancreatic b-cell function is ... post-diagnostic study of the natural history of diabetes ... as a guide to the correct choice of ... to assess b-cell function because of the ...
    ... hormone responsible for the control of glucose metabolism. ... the islets of Langerhans as the precursor, proinsulin, ... Both are secreted in equimolar amounts into ... is comprised of two polypeptide chains, the A-chain ...
    ... quantitative evaluation of pancreatic -cell function is not ... study of the natural history of diabetes mellitus, ... a guide to the correct choice of treatment. ... -cell function because of the large and variable ...
    Medicine Products: